Illumina, INC. SV-451-1003 prod care NSQ 550 comprehensive plan_base period
Ended Purchase Order Awarded Last action
- Contract number
- HHSN261201800088P
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $114,198
Award facts
- Opportunity
-
- N02RC8250961 Solicitation number
- Renewal of Service Contract for Maintenance Agreement for NextSeq 550, Serial number: SV-451-1003. Award Notice · Posted Dec 5, 2017
- Contract value 100% obligated
- $114,198.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 811219 Other Electronic and Precision Equipment Repair and Maintenance
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$11,642 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $33,334 | |
| Exercise an Option | $32,052 | |
| Exercise an Option | $30,819 | |
| Original award | $29,634 |
About this award
This is a $114,198.14 firm fixed price purchase order awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Illumina, Inc. for their NextSeq 550 comprehensive service plan. The contract is not set aside and has an ultimate completion date of July 31, 2024. Illumina is a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, and has previously received prime federal contracts and subcontracts from agencies including the NIH, Centers for Disease Control and Prevention, Department of Agriculture, and Department of Veterans Affairs to provide sequencing instruments, reagents, and related services. The contract provides for Illumina's proprietary NextSeq 550 sequencing system service plan, which likely supports NCI's genomic research and diagnostics efforts.
Quick answers
Who was awarded contract HHSN261201800088P?
HHSN261201800088P was awarded to Illumina, Inc. by National Cancer Institute (National Institutes of Health) on February 1, 2018.
How much is contract HHSN261201800088P worth?
The government has obligated $114,198 on HHSN261201800088P.
Was contract HHSN261201800088P competed?
The extent of competition for HHSN261201800088P was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award